Minor Use Minor Species Development of Drugs (R01)
Last verified by NonDilute: 2026-04-29. Official notice and agency instructions control.
If you're developing a drug for a rare indication or underserved animal species, FDA will help fund the expensive, low-margin clinical work competitors avoid.
Report stale or inaccurate summary
What this is
This R01 grant from the FDA's Center for Drug Evaluation and Research supports pharmaceutical development for minor uses (rare indications in humans) and minor species (less common animals). The program addresses market gaps where drug development is economically unattractive despite medical need. Applicants should have drug development expertise and a specific candidate therapeutic targeting an underserved minor use or animal species indication.
Who can apply
Eligibility details are not specified in the source material. Typically, FDA R01 grants support domestic public and private entities including universities, hospitals, non-profits, and commercial companies; applicants should contact the FDA directly to confirm organizational and project-specific requirements.
Topics: minor use drugs · minor species veterinary · fda drug development · orphan indications · pharmaceutical r&d · unmet medical need
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.